The 11th BIC International Conference is addressed to a relatively narrow selection of medical specialties since it is meant to feature only the most novel advances of basic science and clinical research in haemophilia, rare inherited coagulation disorders, von Willebrand factor and von Willebrand disease, gene therapy, the thrombotic microangiopathies and, of course, factor VIII inhibitors.
We are very happy to announce the 11th BIC International Conference will take place in Venice (Italy) from 17 to 19 September 2021.
The BIC Conference, that has been organized for many years starting as early as in 1983 by the leading staff of the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center in Milan, has gained a reputation among the scientists and clinicians interested in haemostasis and inherited bleeding disorders. This time, as in the previous editions, the main themes will deal with both the haemophilias and von Willebrand disease. In the last decade and particularly in the last few years there have been spectacular advances in this field, stemming from basic science that led to translation implications pertaining the treatment of patients. With this background, a blend of new discoveries in both basic and clinical science will be featured by the invited speakers, chosen by the International Scientific Committee among those scientists that are committing to present new data as yet unpublished and discuss them with their peers. In addition to the scientific sessions, it is a tradition of the BIC Conference to have lively sessions based upon original abstracts competitively submitted by investigators other than those invited by the Scientific Committee. Moreover, pharmaceutical companies will have the opportunity to organize a limited number of sponsored satellite sessions, that are particularly cogent and welcome at a time when so many amazing novelties are occurring for the management of those diseases that are the nugget of the conference.
On the whole, the tradition and the well consolidated format of this conference should be a guarantee of attraction for scientists and clinicians interested in haemostasis and bleeding disorders. Moreover, the BIC Conference will be able to renovate once more the lively atmosphere of interactions and networking between participants, this time in the frame of the beautiful scenario of Venice, that everybody knows to be a uniquely alluring venue.
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
INTERNATIONAL SCIENTIFIC COMMITTEE
Institut National de la Santé et de la Recherche Médicale (INSERM) U1176, Le Kremlin-Bicetre, France
Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 1138, Centre de Recherche des Cordeliers Paris, France
Inserm U770, Le Kremlin-Bicêtre, France
Department of Pathology and Molecular Medicine, Richardson Laboratory, Queen’s University, Kingston (ON), Canada
University of Sheffield, Sheffield Haemophilia and Thrombosis Centre, Sheffield, UK
Irish Haemophilia Society, Ireland
Department of Plasma Proteins – Sanquin Research and University of Amsterdam, Amsterdam, the Netherlands
LOCAL ORGANISING COMMITTEE
Former Director of the Hemophilia and Thrombosis Center of the Bari University Hospital. Coordinator of the Technical Panel on Thrombosis of the Apulia Region, Bari, Italy
Associate Professor of Hematology at the Department of Internal Medicine, University of Milan and Head of Hematology and Transfusion Medicine at the University Hospital L. Sacco of Milan, Italy